Juan Ignacio Enghelmayer

University of Buenos Aires

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Trends

Author Order

Document Type

Co-Authors

Gabriela Tabaj

Instituto Nacional del Tórax

Tulio Papucci

Centro Científico Tecnológico - Bahía Blanca

Sílvia Quadrelli

University of Buenos Aires

Brenda Varela

Hospital Alemán

Silvana Acuña

Hospital de Clínicas "José de San Martín"

María Otaola

Instituto Nacional de Rehabilitación Psicofísica

Cora Gabriela Legarreta

University of Buenos Aires

Javier Sebastiani

Hospital Privado de Comunidad

Federico Campins

Hospital Privado de Comunidad

Diana Lancellotti

Hospital Privado de Comunidad

Cooperative Institutions

Royal Prince Alfred Hospital

Hospital de Clínicas "José de San Martín"

University of Buenos Aires

Isabela State University

University of Colorado Denver

Royal Brompton Hospital

Imperial College London

Lung Institute

National Jewish Health

University of Colorado Anschutz Medical Campus

Author Statistics

Papers

Citation

H-Index

i-10 index

Research Field

Ateneo de la sección de patología difusa y/o intersticial AAMR: Paciente de 61 años con s índrome de Sjögren y compromiso pulmonar

Gabriela Tabaj Brenda Villalobos Varela Sílvia Quadrelli María Otaola Juan Ignacio Enghelmayer

Cite

Citations (0)

Exercise-induced bronchoconstriction in a school-age cohort: Prevalence, risk factors and utility of the Cooper test for its routine detection

European Respiratory Journal (2014)

Hernán A. Iannella Sebastián Rost Vence Juan Ignacio Enghelmayer Carlos M. Luna

Background : Exercise-induced bronchoconstriction (EIB) is a prevalent condition that is frequently underdiagnosed and affects athletic performance, even in subjects without a previous diagnosis of asthma. We hypothesized that the Cooper test could be useful for the routine detection of EIB in the school-age population. Methods : Observational study that included students aged 11-17 who attend a private school in Lavallol, Buenos Aires. The Cooper test was performed in an outdoor setting, and spirometry was performed in each subject before and 10-30 minutes after running. EIB was diagnosed if there was a fall in FEV 1 ≥ 10% from the pre-exercise level. Results : 176 subjects were able to perform a spirometric maneuver and completed the Cooper test, and were included in the analysis. Of these, 45 (25.5%) met EIB criteria. Significant differences were found between the two groups for the presence of a previous diagnosis of asthma (5 vs 3, P=0.014), with a prevalence of EIB in asthmatic patients of 62.5%. No significant differences were found for the remaining variables (Table 1). Conclusions : The Cooper test was able to detect EIB in a significant number of asymptomatic students. Most of the subjects did not have a known diagnosis of asthma. This test could be useful for the routine detection of EIB in schools.

Source

Cite

Citations (0)

A Patient With Severe Steroid-Resistant Bronchiolitis Obliterans: A Case Report

CHEST Journal (2012)

Juan Ignacio Enghelmayer Hector Defranchi Luis Alejandro Márquez–Martínez

10.1378/chest.1390047

Cite

Citations (1)

Hepatitis autoinmune y enfermedad pulmonar intersticial difusa. Una asociación poco frecuente: a propósito de un caso

Juan Ignacio Enghelmayer Tulio Papucci Cora Gabriela Legarreta Julio Silio Luciano Melatini

Abstract A Patient with Autoimmune Hepatitis and Interstitial Lung Disease Autoimmune diseases can compromise the lung, for example the connective tissue di...

Cite

Citations (0)

Comparison of ILD at risk of PH between transplant center and referral care settings

12.01 - Idiopathic interstitial pneumonias (2024)

Brenda Varela Joaquín Maritano Furcada Luciano Melatini Sabino Deleo Gabriela Tabaj

Center (category theory)

10.1183/13993003.congress-2024.pa5157

Cite

Citations (0)

Desaturación en la prueba de marcha de 6 minutos: Su relación con predictores de mortalidad en EPOC

Revista Americana de Medicina Respiratoria (2010)

Juan Ignacio Enghelmayer Tulio Papucci Sergio Scrimini Enrique C. Jolly Ricardo Gené

Background: The distance walked in a 6-minute walk test (6MWT) predicts mortality in severe Chronic Obstructive Pulmonary Disease (COPD). Little is known ab...

Source

Cite

Citations (2)

Proteinosis alveolar pulmonar: Una puesta al día

Revista americana de medicina respiratoria (2014)

Gabriela Tabaj Juan Ignacio Enghelmayer Glenda Ernst Liliana Castro Zorrilla Mirta Scarinci

Pulmonary Alveolar Proteinosis: Up to Date Pulmonary alveolar proteinosis (PAP) is a rare disorder characterized by the accumulation of surfactant lipids and protein in the alveolar spaces, resulting in impairment in gas exchange. The clinical course can be variable, ranging from spontaneous resolution to respiratory failure and death. There are three forms of PAP: congenital, acquired and idiopathic, being the latter the most prevalent form in the adult population. Advances in the understanding of the pathophysiology of PAP demonstrate that the idiopathic form is due to antigranulocyte macrophage-colony stimulating factor (GM-CSF) antibodies. All the forms of PAP cause macrophage dysfunction leading to accumulation of the proteinaceous material. PAP is characterized by progressive exertional dyspnea and nonproductive cough with hypoxemia. Bilateral infiltrates are typically present on chest radiograph; high-resolution computed tomography reveals diffuse ground-glass opacities and airspace consolidation with interlobular septal thickening in a characteristic “crazy paving”

Pulmonary alveolar proteinosis

Chest radiograph

Alveolar macrophage

Pulmonary alveolus

Pathophysiology

Source

Cite

Citations (0)

Antisynthetase syndrome related interstitial lung disease may have a better treatment response than other forms of Idiopathic Inflammatory Myopathies: a multi-national study

Juan Ignacio Enghelmayer Florencia Vivero Sebastián Leiva Agüero Sílvia Quadrelli Diana Lancelloti

Background: Interstitial lung disease (ILD), is the main cause of mortality in Idiopathic inflammatory myopathy (IIM). Epidemiological, prognostic and treatment information are scarce. The goal was to characterize a cohort of IIM patients and compare response to immunosuppression (IS) among different types of IIM. Methods: Observational, multi-centric study in 30 centers from Argentina and Uruguay. Outcomes: Response to IS was defined as worsening: decline FVC >10%; improvement: increase FVC >10%; stability: changes FVC <10% at 6-12 months; Fisher test was used and OR was calculated by using contingency tables to assess the association of categorical variables. Results: We studied 56 patients with IIM; mean age 51 years; 77% women. 64% patients had anti-synthetase syndrome (ASS), and 36% had demarto/polymyositis. Mean FVC at baseline was 65 % and mean DLCO 55%. Tomographic patterns were nonspecific interstitial pneumonia (NSIP) in 46%, organizing pneumonia (OP) in 12%, overlap NSIP/OP in 17%. Only 55% had positive ANA. From ANA negative patients, 54% had at least one Anti-tRNA-synthetase antibody. Glucocorticoid (GC) were used in 95% of patients. 30% received GC pulses. Other IS drugs were cyclophosphamide, mycophenolate and azathioprine. For the overall cohort the outcomes were: stability 62%, improvement 32% and worsening 6% at 6-12 months. When analyzing response to IS, ASS had a better treatment response than other forms of IIM (OR 1.97 [95%CI 1.06-3.34]; p=0.03) for stability or improvement. Conclusions: ASS related ILD had a better treatment response than other forms of IIM in our cohort. ANA is often negative.

Antisynthetase syndrome

DLCO

10.1183/13993003.congress-2020.806

Cite

Citations (1)

Evolución de la función pulmonar en la enfermedad intersticial pulmonar asociada a esclerodermia tratada con ciclofosfamida: Análisis retrospectivo de una serie de casos en un hospital universitario

Revista Americana de Medicina Respiratoria (2014)

Juan Ignacio Enghelmayer Vanina Giovini Silvana Acuña Cora Gabriela Legarreta Soledad Altube

Introduction: In spite of its limited efficacy, cyclophosphamide (CYC) is frequently used to treat scleroderma-associated interstitial lung disease (SSc-IL...

Source

Cite

Citations (0)

Shrinking lung syndrome in systemic lupus erythematosus: A study of 9 patients

Medicina Clínica (English Edition) (2024)

Alberto Casey Juan Ignacio Enghelmayer Cora Gabriela Legarreta A. Béron María Marta Perín

10.1016/j.medcle.2023.10.024

Cite

Citations (0)